SeaStar Medical Shares Rise 13% After FDA Approvable Letter
By Chris Wack SeaStar Medical Holding shares were up 13% to $1.15 after the company said the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research has issued an...
Source: marketscreener.com